Phibro Animal Health (NASDAQ: PAHC) reported Q3 EPS of $0.21, or $0.36 on a pro forma basis (+28%), versus $0.14 last year. Revenue for the quarter came in at $173.3 million up 7% from the $162.7 million reported last year.

Phibro Animal Health sees Q4 2014 EPS of $0.21-$0.24. Phibro Animal Health sees Q4 2014 revenue of $174-177 million.

Phibro Animal Health sees FY2014 EPS of $1.19-$1.22. Phibro Animal Health sees FY2014 revenue of $682-685 million.

Affirms plan to pay $0.10 per share quarterly dividend, beginning September 2014

"We welcome the investing community to our first earnings release as a public company. For the March 2014 quarter, our Animal Health-focused growth initiatives continued to deliver strong sales and profit growth," said Jack Bendheim, Chairman, President and Chief Executive Officer. "We see good operating momentum going into the final quarter of our fiscal year and we continue to look for tuck-in acquisitions."

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.